These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38014070)

  • 1. High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines.
    Joseph JO; Ylade M; Daag JV; Aogo R; Crisostomo MV; Mpingabo P; Premkumar L; Deen J; Katzelnick L
    Res Sq; 2023 Nov; ():. PubMed ID: 38014070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines.
    Joseph JO; Ylade M; Daag JV; Aogo R; Crisostomo MV; Mpingabo P; Premkumar L; Deen J; Katzelnick LC
    BMC Infect Dis; 2024 Sep; 24(1):1042. PubMed ID: 39333882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
    Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H
    Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
    Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
    Front Immunol; 2022; 13():954093. PubMed ID: 36159791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.
    Adami FL; de Castro MV; Almeida BDS; Daher IP; Yamamoto MM; Souza Santos K; Zatz M; Naslavsky MS; Rosa DS; Cunha-Neto E; de Oliveira VL; Kalil J; Boscardin SB
    Front Immunol; 2024; 15():1396603. PubMed ID: 38846944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.
    Wang J; Li D; Zhou Q; Wiltse A; Zand MS
    Front Immunol; 2021; 12():696370. PubMed ID: 34386006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of endemic human coronavirus infection during the COVID-19 pandemic.
    Kakuya F; Terao R; Onoda H; Okubo H; Fujiyasu H; Inyaku F; Fukuura A; Arai T; Kinebuchi T
    J Infect Chemother; 2024 May; 30(5):400-405. PubMed ID: 37979777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
    Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of endemic coronaviruses during the COVID-19 pandemic in Iran, 2021-2022.
    Karami H; Sadeghi K; Zadheidar S; Saadatmand F; Mirsalehi N; Ardestani NH; Kalantari S; Farahmand M; Yavarian J; Mokhtari-Azad T
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13128. PubMed ID: 36970571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dominance of human coronavirus OC43 and NL63 infections in infants.
    Dijkman R; Jebbink MF; Gaunt E; Rossen JW; Templeton KE; Kuijpers TW; van der Hoek L
    J Clin Virol; 2012 Feb; 53(2):135-9. PubMed ID: 22188723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.
    Karaba AH; Johnston TS; Beck E; Laeyendecker O; Cox AL; Klein SL; Sullivan DJ;
    mBio; 2023 Feb; 14(1):e0328722. PubMed ID: 36625657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers.
    Egwang TG; Owalla TJ; Okurut E; Apungia G; Fox A; De Carlo C; Powell RL
    Int J Infect Dis; 2021 Nov; 112():165-172. PubMed ID: 34547496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Non-SARS-CoV2 Human Coronaviruses (HCoVs) in People Presenting with Influenza-like Illness (ILI) or Severe Acute Respiratory Infections (SARI) in Senegal from 2012 to 2020.
    Faye MN; Barry MA; Jallow MM; Wade SF; Mendy MP; Sy S; Fall A; Kiori DE; Ndiaye NK; Goudiaby D; Diamanka A; Niang MN; Dia N
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Culture Methods for Human Coronaviruses HCoV-OC43, HCoV-229E, and HCoV-NL63.
    Fausto A; Otter CJ; Bracci N; Weiss SR
    Curr Protoc; 2023 Oct; 3(10):e914. PubMed ID: 37882768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses.
    Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity.
    Brown JA; Hauser A; Abela IA; Pasin C; Epp S; Mohloanyane T; Nsakala BL; Trkola A; Labhardt ND; Kouyos RD; Günthard HF
    J Infect Dis; 2023 Oct; 228(8):1042-1054. PubMed ID: 37261930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.